The European Court of Justice ruled last week that Hamas is not a terrorist group after all. The decision is the latest indication of Europe’s increasing embrace of the Palestinian cause and vexation with Israel.
The European Union excludes Israeli entities outside the Green Line from its loan programs and its competitions for grants and prizes, but Israel will nonetheless be able to participate in the Union’s flagship research and development program, Horizon 2020, the Jerusalem Post reported.
Among our Lamentations this week was the news on Tisha b’Av that the European Union would cease all funding and cooperation with Israeli activity beyond the Green Line (1967 borders). This diplomatic and economic ostracism includes not only the entirety of the West Bank but even the Jewish Quarter of Jerusalem — the place, of course, of the Temple Mount and Kotel, our holiest sites.
Israeli pharmaceutical standards equal Europe's, can be marketed there without further control.
The European Parliament voted in favor of simplifying the sale of Israeli pharmaceuticals within the European Union.
With Tuesday's vote in Strasbourg, France, the parliament approved “a very important technical-commercial agreement,” Yigal Palmor, a spokesman for the Israeli Ministry of Foreign Affairs, told JTA in an email.